LSE - Delayed Quote GBp
Shield Therapeutics plc (STX.L)
2.3500
+0.0900
+(3.98%)
At close: April 25 at 4:08:39 PM GMT+1
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Anders Lundstrom | CEO & Executive Director | 42k | -- | 1962 |
| Dr. Christian Schweiger M.D., Ph.D. | Co-Founder & Non Executive Director | 37k | -- | 1966 |
| Mr. Santosh Shanbhag | Chief Financial Officer | -- | -- | 1978 |
| Ms. Lucy Kate Huntington-Bailey | General Counsel & Company Secretary | -- | -- | -- |
| Ms. Suzanne Wood | Group HR Director | -- | -- | -- |
| Ms. Carol Akinola | Head of Pharmacovigilance & Medical Information | -- | -- | -- |
| Mr. Andrew Hurley | Chief Commercial Officer | -- | -- | 1969 |
| Kate Armanetti | Senior Director of People & Culture | -- | -- | -- |
Shield Therapeutics plc
Northern Design Centre
Baltic Business Quarter
Gateshead, NE8 3DF
United Kingdom
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Description
Shield Therapeutics plc, a commercial stage specialty pharmaceutical company, focuses on commercialization of pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Feraccru, a non-salt based oral therapy for adults to treat the iron deficiency with or without anemia. Shield Therapeutics plc was incorporated in 2008 and is based in Gateshead, the United Kingdom.
Corporate Governance
Shield Therapeutics plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
April 24, 2025 at 6:06 AM UTC
Shield Therapeutics plc Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
AEQ.F Aequus Pharmaceuticals Inc.
0.0005
0.00%
5SS0.F Simply Better Brands Corp.
0.5340
+3.49%
GENIL.IS Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi
121.30
+1.08%
GABA.ST Gabather AB (publ)
0.0396
-2.94%
VCBD Vitalibis, Inc.
0.0018
+28.57%
GHG.CN Global Hemp Group Inc.
0.0200
0.00%
KLAR.ST Klaria Pharma Holding AB (publ.)
1.1500
-3.77%
TGIF.CN 1933 Industries Inc.
0.0050
0.00%
4502.T Takeda Pharmaceutical Company Limited
4,275.00
+0.38%
CRNO-B.ST Cereno Scientific AB (publ)
8.00
+0.38%